Breaking News Instant updates and real-time market news.

PCLN

Ticker changed to BKNG

$0.00

(0.00%)

, EOG

EOG Resources

$108.53

-0.96 (-0.88%)

14:19
02/27/18
02/27
14:19
02/27/18
14:19

Notable companies reporting after market close

Notable companies reporting after the market close, with earnings consensus, include Priceline (PCLN), consensus $14.12... EOG Resources (EOG), consensus 52c... Express Scripts (ESRX), consensus $2.09... Workday (WDAY), consensus 20c... Square (SQ), consensus 7c... Altice USA (ATUS), consensus (1c)... Albemarle (ALB), consensus $1.21... Live Nation (LYV), consensus ($1.08)... Veeva Systems (VEEV), consensus 21c... HEICO (HEI), consensus 40c... Middleby (MIDD), consensus $1.50... BWX Technologies (BWXT), consensus 46c... RSP Permian (RSPP), consensus 32c... DexCom (DXCM), consensus 3c... Weight Watchers (WTW), consensus 31c... Envision Healthcare (EVHC), consensus 50c... MasTec (MTZ), consensus 37c... Outfront Media (OUT), consensus 27c... Etsy (ETSY), consensus 9c... B&G Foods (BGS), consensus 56c... Papa John's (PZZA), consensus 67c... Hertz Global (HTZ), consensus (60c)... IMAX (IMAX), consensus 32c.

PCLN

Ticker changed to BKNG

$0.00

(0.00%)

EOG

EOG Resources

$108.53

-0.96 (-0.88%)

ESRX

Express Scripts

$77.64

0.64 (0.83%)

WDAY

Workday

$127.80

0.47 (0.37%)

SQ

Square

$46.38

-0.17 (-0.37%)

ATUS

Altice USA

$18.79

-0.4 (-2.08%)

ALB

Albemarle

$111.94

1.84 (1.67%)

LYV

Live Nation

$47.98

-0.61 (-1.26%)

VEEV

Veeva

$62.64

0.54 (0.87%)

HEI

Heico

$82.68

0.86 (1.05%)

MIDD

Middleby

$131.07

-3.28 (-2.44%)

BWXT

BWX Technologies

$64.26

-0.56 (-0.86%)

RSPP

RSP Permian

$36.09

-0.61 (-1.66%)

DXCM

DexCom

$56.97

0.61 (1.08%)

WTW

Weight Watchers

$70.13

-1.53 (-2.14%)

EVHC

Envision Healthcare

$36.67

-0.005 (-0.01%)

MTZ

MasTec

$51.80

-0.95 (-1.80%)

OUT

Outfront Media

$21.67

-0.545 (-2.45%)

ETSY

Etsy

$21.12

0.05 (0.24%)

BGS

B&G Foods

$31.60

-0.4 (-1.25%)

PZZA

Papa John's

$57.27

0.07 (0.12%)

HTZ

Hertz

$19.29

-0.73 (-3.65%)

IMAX

Imax

$23.35

-0.3 (-1.27%)

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 05

    Mar

  • 05

    Mar

  • 07

    Mar

  • 07

    Mar

  • 08

    Mar

  • 12

    Mar

  • 13

    Mar

  • 20

    Mar

  • 21

    Mar

  • 22

    Mar

  • 23

    Mar

  • 23

    Mar

  • 02

    May

  • 15

    May

  • 30

    May

PCLN Ticker changed to BKNG
$0.00

(0.00%)

01/30/18
WELS
01/30/18
NO CHANGE
Target $1850
WELS
Market Perform
Priceline price target raised to $1850 from $1800 at Wells Fargo
Wells Fargo analyst Ken Sena raised his price target for Priceline to $1850 from $1800 after assuming "lead" coverage of the stock. The analyst kept a Market Perform rating on the shares.
02/22/18
DBAB
02/22/18
NO CHANGE
Target $2045
DBAB
Hold
Priceline price target raised to $2,045 from $1,825 at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley raised his price target for Priceline to $2,045 but keeps a Hold rating on the shares ahead of the company's Q4 results. He sees investor expectations as "slightly elevated" into the print given "strong (but unreliable)" third-party data, optimism around guidance for room nights and profitability, share buybacks, and "complacency" around Google Travel risk. The analyst expects a "meaningful step up" in the pace of share buybacks in 2018 post tax reform. Walmsley, however, sees more attractive risk/reward scenarios in other large cap Internet names.
02/26/18
MKMP
02/26/18
NO CHANGE
Target $1850
MKMP
Neutral
Priceline 'not attractive' ahead of earnings, says MKM Partners
MKM Partners analyst Rob Sanderson keeps his Neutral rating and $1,850 price target on Priceline ahead of tomorrow's earnings. Sanderson notes that while the stock has risen 11% since December on favorable FX conditions and the positive tax impact, the set-up for earnings is not attractive because Priceline trades at the midpoint of its post-recession valuation range and bookings growth is at all-time lows. The analyst keeps his Neutral rating on Priceline, warning that bookings could decelerate even further.
01/12/18
RHCO
01/12/18
NO CHANGE
Target $2200
RHCO
Buy
Priceline price target raised to $2,200 from $2,000 at SunTrust
SunTrust analyst Youssef Squali kept his Buy rating and raised his price target on Priceline to $2,200 as part of his "Favorite Internet Stocks; Bullish Thesis Strengthened" research note. Squali says the stock is attractive based on the company's fundamentally strong position in online travel space, adding that Priceline has deliberately sacrificed near-term outlook to position itself for sustained growth and profitability. The analyst also notes that the reduced expectations for the company do not reflect the contribution from its TV advertising and SEM/SEO investments.
EOG EOG Resources
$108.53

-0.96 (-0.88%)

01/23/18
FBCO
01/23/18
NO CHANGE
Target $126
FBCO
Neutral
EOG Resources price target raised to $126 from $106 at Credit Suisse
Credit Suisse analyst William Featherston raised his price target for EOG Resources to $126 from $106 on valuation. The analyst reiterates a Neutral rating on the shares.
01/04/18
BOFA
01/04/18
DOWNGRADE
Target $125
BOFA
Neutral
EOG Resources downgraded to Neutral on valuation at BofA/Merrill
As previously reported, BofA/Merrill downgraded EOG Resources to Neutral from Buy and increased its price target to $125 from $115. Analyst Doug Leggate said shares trade at a premium to peers and sees better risk/reward elsewhere.
01/05/18
BARD
01/05/18
NO CHANGE
Target $122
BARD
Outperform
EOG Resources price target raised to $122 from $114 at Baird
Baird analyst Joseph Allman raised his price target on EOG Resources to $122 from $114 as he updated his model to reflect higher oil prices. In addition to higher oil prices, the analyst included the positive impact from the new tax law. Allman reiterated his Outperform rating on EOG Resources shares.
01/08/18
ARGS
01/08/18
NO CHANGE
Target $133
ARGS
Buy
EOG Resources price target raised to $133 from $102 at Argus
Argus analyst Bill Selesky raises his price target on EOG Resources to $133, citing the management's focus on improving returns on invested capital, reducing operating costs, and maintaining a strong balance sheet. Selesky says the company "has become one of the industry's lowest-cost shale drillers", estimating up to 30% ROIC with crude oil trading as low as $40 per barrel. The analyst keeps his Buy rating on EOG Resources, raising his FY17 EPS view to 92c from 71c and 2018 to $2.27 from $1.58 amid the recent strength in crude oil prices and the company's well completions.
ESRX Express Scripts
$77.64

0.64 (0.83%)

02/22/18
BERN
02/22/18
NO CHANGE
BERN
Amazon to accelerate disruption in healthcare, says Bernstein
Bernstein analyst Lance Wilkes believes that disruption is coming for healthcare, and Amazon (AMZN) will be an accelerant of this disruption. Further, the analyst thinks Amazon is developing a series of business strategies for entering the healthcare market segments, and projects that Amazon will develop an online pharmacy to disrupt the existing retail pharmacy market. Overall, Wilkes sees Amazon's strategies as creating downside risks for PBMs including Express Scripts (ESRX).
02/13/18
LEER
02/13/18
NO CHANGE
LEER
Walgreens may seek to acquire AmerisourceBergen sooner than expected, says Leerink
Leerink analyst David Larsen notes that The Wall Street Journal reported that Walgreens (WBA) has approached AmerisourceBergen (ABC) about a potential takeover. The analyst is surprised that talks of such a large transaction have surfaced so quickly following the Rite Aid (RAD) deal, but says he has always believed that Walgreens at some point would seek to acquire either Express Scripts (ESRX) or AmerisourceBergen. Given the broad-based speculation in the business press about this deal, it is possible shares of Express Scripts will trade off, Larsen contends.
02/27/18
BOFA
02/27/18
INITIATION
Target $77
BOFA
Underperform
Express Scripts reinstated with an Underperform at BofA/Merrill
BofA/Merrill analyst Michael Cherny reinstated coverage on Express Scripts with an Underperform and $77 price target.
02/01/18
02/01/18
DOWNGRADE
Target $69

Underperform
Express Scripts downgraded to Underperform at Bernstein
As previously reported, Bernstein analyst Lance Wilkes downgraded Express Scripts to Underperform from Market Perform, with a $69 price target, as he believes tax reform is fully price in and his original concerns on the standalone PBM model remain. Further, the analyst sees additional risks from a potential CVS (CVS)/Aetna (AET) merger and Amazon (AMZN) threats.
WDAY Workday
$127.80

0.47 (0.37%)

02/26/18
MACQ
02/26/18
UPGRADE
MACQ
Neutral
Workday upgraded to Neutral from Underperform at Macquarie
02/22/18
RBCM
02/22/18
NO CHANGE
Target $135
RBCM
Outperform
Workday price target raised to $135 from $115 at RBC Capital
RBC Capital analyst Ross MacMillan raised his price target on Workday to $135 ahead of the company's Q4 earnings, stating that he sees an opportunity for an upward revision in FY19 guidance. MacMillan cites higher traction in Workday's Financials business and continued performance of the company's core HCM, as its upsell opportunity accelerates with the broader product portfolio. The analyst keeps his Outperform rating.
02/20/18
DBAB
02/20/18
NO CHANGE
Target $115
DBAB
Hold
Workday price target raised to $115 from $105 at Deutsche Bank
Deutsche Bank analyst Karl Keirstead raised his price target for Workday to $115 ahead of the company's Q4 results next week. The analyst, however, keeps a Hold rating on the shares. He believes expectations are "relatively high" into the print.
02/20/18
PIPR
02/20/18
NO CHANGE
Target $135
PIPR
Overweight
Workday checks show 'very strong quarter, ' says Piper Jaffray
Piper Jaffray analyst Alex Zukin says his channel checks suggest a "very strong quarter" for Workday, punctuated by "multiple large Fortune 100 HCM wins as well as at least two marquee financials wins." The company reports Q4 results on February 27. The analyst also views the company's mid-20% preliminary fiscal 2019 subscription revenue guidance as conservative. He remains a buyer of Workday shares with an Overweight rating.
SQ Square
$46.38

-0.17 (-0.37%)

01/04/18
BUCK
01/04/18
INITIATION
Target $42
BUCK
Buy
Square initiated with a Buy at Buckingham
Buckingham analyst Chris Brendler initiated Square with a Buy and $42 price target saying it unique tech disruptor that is in the early stages of its global opportunity. Brendler said Square has a dominant SMB-focused payments franchise and high-margin software solutions scaling rapidly, which should continue to drive recent momentum.
02/21/18
KEYB
02/21/18
NO CHANGE
Target $52
KEYB
Overweight
Square price target raised to $52 from $40 at KeyBanc
KeyBanc analyst Josh Beck raised his price target for Square to $52 from $40 and says he would be a buyer of the stock as he believes the potential of the platform remains undervalued on an EV/EBITDA/G basis. The analyst expects a strong Q4 beat, followed by a conservative, yet beatable guidance factoring in reinvestment. He reiterates an Overweight rating on the shares.
01/19/18
NOMU
01/19/18
NO CHANGE
Target $64
NOMU
Buy
Square price target raised to $64 from $48 at Nomura Instinet
Nomura Instinet analyst Dan Dolev raised his price target for Square to $64, which represents 59% potential upside from current levels. A "looming positive inflection" in gross payment volume growth can help "ensure that 2018 will be yet another phenomenal year" for Square, Dolev tells investors in a research note. Accelerating share gains from payment peers and "relentless disruption of services" like payroll and human resource will make Square a very different company in 10 years, the analyst contends. He believes little of this upside is evident using conventional valuation methodologies. The analyst keeps a Buy rating on Square.
01/04/18
01/04/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with a Buy at Buckingham. 2. Tyme Technologies (TYME) initiated with a Buy at Canaccord. 3. Visteon (VC) initiated with a Buy at Guggenheim. 4. Core-Mark (CORE) initiated with an Outperform at William Blair. 5. PJT Partners (PJT) initiated with a Neutral at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ATUS Altice USA
$18.79

-0.4 (-2.08%)

01/23/18
LEHM
01/23/18
UPGRADE
Target $26
LEHM
Overweight
Altice USA upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Kannan Venkateshwar upgraded Altice USA (ATUS) to Overweight and raised his price target for the shares to $26 from $22. The recently announced spin by Altice NV (ALLVF) should address many of the concerns around Altice USA's complex holding structure, high leverage across the group, and operational slowdown at the parent, Venkateshwar tells investors in a research note. Further, the company's decision to buy back stock and reduce leverage near term should add more credibility to its margin guidance, the analyst adds.
02/09/18
MSCO
02/09/18
NO CHANGE
Target $35
MSCO
Equal Weight
Lionsgate progress with Altice could help FY19, says Morgan Stanley
Lionsgate analyst Benjamin Swinburne noted that Lionsgate's (LGF.A) Q3 results were broadly in-line with expectations, although Starz subscriber metrics were lower than expected and the company lowered its three year growth expectation to mid to high single digits. However, Lionsgate mentioned on its earnings call that it continues to talk to Altice (ATUS) and hopes an agreement can be reached "imminently," which could be a benefit to FY19, noted Swinburne, who keeps an Equal Weight rating and $35 price target on Lionsgate shares.
12/13/17
SOCG
12/13/17
INITIATION
SOCG
Buy
Altice USA initiated with a Buy at Societe Generale
11/14/17
RBCM
11/14/17
NO CHANGE
Target $35
RBCM
Outperform
Altice USA price target lowered to $35 from $40 at RBC Capital
RBC Capital analyst Jonathan Atkin lowered his price target on Altice USA to $35 but kept his Outperform rating following the company's Q3 earnings miss on November 2nd. Atkin says the subsequent sell-off is driven by operating concerns at the parent company rather than specific challenges for the U.S. unit, adding that the current valuations are attractive.
ALB Albemarle
$111.94

1.84 (1.67%)

02/26/18
02/26/18
DOWNGRADE
Target $44

Underweight
SQM downgraded to Underweight with $44 price target at Morgan Stanley
As previously reported, Morgan Stanley analyst Javier Martinez de Olcoz Cerdan downgraded SQM (SQM) to Underweight from Equal Weight as he expects lithium prices to peak in 2018 then decline by 45% by 2021 as demand growth falls "far short" of sharp supply increases. Additionally, new supply is low cost and will transfer share from the high end to the low end of the cost curve, added the analyst. While cutting his rating to Underweight, Martinez de Olcoz Cerdan also called SQM the "best-quality lithium player globally" and increased his price target on the stock to $44 from $32.50. Morgan Stanley analyst Vincent Andrews also downgraded Albemarle (ALB) to Underweight this morning, citing his concerns on both the lithium supply and demand side.
02/26/18
02/26/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Albermarle (ALB) downgraded to Underweight from Equal Weight at Morgan Stanley by analyst Vincent Andrews, who cited concerns on both the lithium supply and demand side. On the lithium demand side, bulls' electric vehicle penetration rate forecasts seem "aggressive, said Andrews. He also now has material concerns on the supply side following the recent Chilean government agreement with SQM (SQM), added Andrews. SQM was also downgraded to Underweight from Equal Weight at Morgan Stanley by analyst Javier Martinez de Olcoz Cerdan. 2. Halliburton (HAL) downgraded to Neutral from Buy at BofA/Merrill by analyst Timna Tanners, who said the U.S. shale story is maturing and there are limited catalysts for shares. Tanners expects a more muted response to high oil prices given newbuiilds coming into the market in 2018. 3. Aqua America (WTR) downgraded to Market Perform from Outperform at Wells Fargo by analyst Jonathan Reeder, who cited valuation and said he prefers shares of American Water (AWK) at current levels. 4. Mattel (MAT) downgraded to Underperform from Hold at Jefferies by analyst Stephanie Wissink. The shares currently reflect an "aggressive" sales and profit recovery to 15% margins in 2020, Wissink said, however, believes industry conditions are challenging recovery assumptions. 5. Empire State Realty (ESRT) downgraded to Hold from Buy at Stifel by analyst John Guinee, who said he expects 2018 to be a "difficult year for value creation metrics" and notes his FFO estimates continue to decline. Guinee added that the Manhattan investment market is highly competitive and that he's not convinced the company will deploy the cash balance into new investments any time soon. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/26/18
MSCO
02/26/18
DOWNGRADE
MSCO
Underweight
Albemarle downgraded to Underweight from Equal Weight at Morgan Stanley
02/26/18
MSCO
02/26/18
DOWNGRADE
Target $85
MSCO
Underweight
Morgan Stanley cuts Albemarle to sell with concerns on both supply and demand
As previously reported, Morgan Stanley analyst Vincent Andrews downgraded Albemarle (ALB) to Underweight, the firm's sell-equivalent rating, from Equal Weight citing his concerns on both the lithium supply and demand side. On the lithium demand side, bulls' electric vehicle penetration rate forecasts seem "aggressive, said Andrews. He also now has material concerns on the supply side following the recent Chilean government agreement with SQM (SQM), added Andrews, who lowered his price target on Albermarle to $85 from $100. Morgan Stanley analyst Javier Martinez de Olcoz Cerdan also downgraded SQM to Underweight this morning.
LYV Live Nation
$47.98

-0.61 (-1.26%)

11/20/17
11/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) downgraded to Neutral from Buy at Goldman Sachs with analyst Matthew Fassler sayign valuation following "powerful" share appreciation now reflects the company's progress in growing earnings. 2. Five Below (FIVE) downgraded to Hold from Buy at Loop Capital with analyst Anthony Chukumba citing valuation. 3. Live Nation (LYV) downgraded to In Line from Outperform at Evercore ISI with analyst David Joyce citing valuation. 4. Monster Beverage (MNST) downgraded to Negative from Neutral at Susquehanna with analyst Pablo Zuanic citing its high valuation, which he believes is misplaced due to assumptions about an offer from Coca-Cola (KO). 5. Deutsche Bank (DB) downgraded to Underperform from Market Perform at Keefe Bruyette. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/22/17
SBSH
12/22/17
DOWNGRADE
Target $47
SBSH
Neutral
Live Nation downgraded to Neutral from Buy at Citi
Citi analyst Jason Bazinet downgraded Live Nation to Neutral while raising his price target for the shares to $47 from $45. The benefits from tax reform is insufficient to justify the outperformance of the stock in 2017, Bazinet tells investors in a research note. He cites valuation for the downgrade.
12/22/17
12/22/17
DOWNGRADE

On The Fly: Top analyst downgrades
Catch up on today's top analyst downgrades with this list compiled by The Fly: 1. Dynagas LNG (DLNG) downgraded to Hold from Buy at Stifel with analyst Benjamin Nolan saying although the new three-year contract extension with Statoil (STO) improves cash flow visibility, the rates were below expectations and the cash flow gap has widened. 2. Hovnanian (HOV) downgraded to Sell from Neutral at MKM Partners wiht analyst Megan McGrath saying the large positive move up on the heels of its earnings report followed what she viewed as "only a mildly positive quarter." 3. Bojangles (BOJA) was downgraded to Hold from Buy at Jefferies while Wingstop (WING) and Shake Shack (SHAK) were downgraded to Underperform from Hold. 4. WWE (WWE) and Live Nation (LYV) were downgraded to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/22/17
SBSH
12/22/17
DOWNGRADE
Target $33
SBSH
Neutral
WWE downgraded to Neutral from Buy at Citi
Citi analyst Jason Bazinet downgraded WWE (WWE) to Neutral while raising his price target for the shares to $33 from $29. The benefit from tax reform is insufficient to justify the outperformance of the stock in 2017, Bazinet tells investors in a research note. He cites valuation for the downgrade. The analyst this morning also downgraded Live Nation (LYV) to Neutral for a similar rationale. Bazinet keeps a Buy rating on Formula One Group (FWONA) with a $44 price target.
VEEV Veeva
$62.64

0.54 (0.87%)

01/30/18
MSCO
01/30/18
UPGRADE
MSCO
Overweight
Veeva upgraded to Overweight from Equal Weight at Morgan Stanley
02/02/18
DADA
02/02/18
INITIATION
Target $75
DADA
Buy
Veeva initiated with a Buy at DA Davidson
DA Davidson analyst Rishi Jaluria initiated Veeva with a Neutral rating and a price target of $28, tagging the company as the "top pick in software" because of its "sustainable competitive advantage, multiple growth drivers, and leading balance of growth and profitability". Jaluria cites Veeva's domain expertise and established relationships with top pharmaceutical companies creating a "sustainable moat", outperforming content management platform, and the focus on fiscal discipline.
01/30/18
01/30/18
UPGRADE
Target $72

Overweight
Veeva upgraded to Overweight on margin potential at Morgan Stanley
As previously reported, Morgan Stanley analyst Stan Zlotsky upgraded Veeva to Overweight from Equal Weight, citing its underappreciated gross margin opportunity. Veeva's gross renewal rates are best-in-class and he does not expect that to change, said Zlotsky, who estimates the company can drive up its blended gross margin to 79% by FY33 from 72% today. The analyst increased his price target on Veeva shares to $72 from $69.
02/21/18
MSCO
02/21/18
NO CHANGE
Target $72
MSCO
Overweight
Veeva checks suggest strong Vault momentum in Q4, says Morgan Stanley
Morgan Stanley analyst Stan Zlotsky said his Q4 checks on Veeva made him incrementally more positive on the sustainability of Vault's growth entering FY19. Along with healthy underlying trends, he also sees upside to conservative FY19 estimates, said Zlotsky, who keeps an Overweight rating and $72 price target on Veeva shares ahead of the company's Q4 report next week.
HEI Heico
$82.68

0.86 (1.05%)

12/19/17
ADAM
12/19/17
NO CHANGE
Target $95
ADAM
Buy
Heico results, guidance could be positive catalyst, says Canaccord
Canaccord analyst Ken Herbert said Heico's "strong" Q4 results and "conservative" 2018 guidance could be a positive catalyst for the shares. While the guidance was conservative in his view, he believes the stock will react well to the strong results, specifically the strong outlook for defense sales. Herbert reiterated his Buy rating and $95 price target on Heico shares.
12/20/17
FBCO
12/20/17
NO CHANGE
Target $109
FBCO
Outperform
Heico price target raised to $109 from $98 at Credit Suisse
Credit Suisse analyst R. Spingarn raised his price target for Heico to $109 from $98 saying he remains constructive on the shares despite the premium valuation and the recent run in the stock. The analyst reiterates an Outperform rating on the shares.
01/08/18
JEFF
01/08/18
UPGRADE
Target $113
JEFF
Buy
Heico upgraded to Buy from Hold at Jefferies
Jefferies analyst Sheila Kahyaoglu upgraded Heico Corporation to Buy and raised her price target for the shares to $113 from $103. Accelerating organic revenue combined with acquisition contribution are likely to outpace fiscal 2018 guidance, Kahyaoglu tells investors in a research note. The analyst believes strong free cash flow generation and Heico's low leverage could result in additional inorganic earnings accretion.
12/20/17
ADAM
12/20/17
NO CHANGE
Target $110
ADAM
Buy
Heico price target raised to $110 from $95 at Canaccord
Canaccord analyst Ken Herbert raised his price target on Heico to $110 from $95 following its better than expected Q4 results. The analyst raised his estimates to reflect a higher contribution from acquisitions than is in the full year guidance and he believes the transition to stronger growth in defense markets will not negatively impact the stocks' valuation. Herbert reiterated his Buy rating on Heico shares.
MIDD Middleby
$131.07

-3.28 (-2.44%)

10/16/17
KEYB
10/16/17
DOWNGRADE
KEYB
Sector Weight
Middleby downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst James Picariello downgraded Middleby to Sector Weight citing expectations for a more moderate pick-up in Commercial Foodservice core sales into 2018. The analyst sees greater risk of downside earnings surprises next year.
09/27/17
SUSQ
09/27/17
INITIATION
Target $141
SUSQ
Positive
Middleby initiated with a Positive at Susquehanna
Susquehanna analyst Robert Barry initiated Middleby with a Positive and $141 price target.
08/15/17
BMOC
08/15/17
NO CHANGE
BMOC
Middleby weakness creates long-term opportunity, says BMO Capital
BMO Capital analyst Joel Tiss says that Middleby's lower than expected sales for the last two quarters have created a buying opportunity for longer term investors. He thinks that sales are being delayed because it is taking time for buyers to customize Middleby's offerings and get approval for the high prices of Middleby's products which are "more revolutionary" than those of its competitors. Tiss expects the company's organic growth to accelerate sharply toward the end of this year and through 2019. He keeps a $150 price target and an Outperform rating on the stock.
08/15/17
MACQ
08/15/17
UPGRADE
MACQ
Outperform
Middleby upgraded to Outperform from Neutral at Macquarie
Macquarie analyst James Clement upgraded Middleby to Outperform and raised its price target to $150 from $140 citing attractive valuation and reduced expectations. The analyst believes restaurants are buying equipment that reduces labor costs and increases automation, and thinks the trend will lengthen Middleby's sales cycle, which explains why management sees that $300M in sales starting in Q3.
BWXT BWX Technologies
$64.26

-0.56 (-0.86%)

11/08/17
BARD
11/08/17
NO CHANGE
Target $70
BARD
Outperform
BWX Technologies weakness a buying opportunity, says Baird
Baird analyst Peter Arment said the recent pullback in BWX Technologies is a buying opportunity. He attributed the pullback to concerns surrounding earnings growth in 2018, but he sees current issues as transitory and expects double digit growth in 2019 and beyond. Arment reiterated his Outperform rating and $70 price target on BWX Technology shares.
12/11/17
WELS
12/11/17
INITIATION
Target $65
WELS
Market Perform
BWX Technologies initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Sam Pearlstein started BWX Technologies with a Market Perform rating and $65 price target. The analyst has a cautious near-term stance on the shares citing the "high current valuation" and "relatively poor" cash generation expected in 2018.
12/11/17
12/11/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with a Market Perform on valuation at Cowen. 2. Illinois Tool Works (ITW) initiated with a Buy at BofA/Merrill. 3. SendGrid (SEND) was initiated with an Outperform at William Blair, an Overweight at Piper Jaffray, KeyBanc, and JPMorgan, a Buy at Stifel, as well as an Equal Weight at Morgan Stanley. 4. BWX Technologies (BWXT) initiated with a Market Perform at Wells Fargo. 5. Arsanis (ASNS) was initiated with an Overweight at Piper Jaffray, an Outperform at Cowen, and a Buy at Citi. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/18
GHSC
01/10/18
INITIATION
Target $72
GHSC
Buy
BWX Technologies initiated with a Buy at Seaport Global
Seaport Global analyst Josh Sullivan initiated BWX Technologies with a Buy and $72 price target. The analyst said shares have benefited from navy build schedules but the next beig catalysts is the underappreciated medical radioisotope market. Sullivan believes BWX has developed a disruptive medical radioisotope process for which the first isotope is potentially a $1B product that could provide a path for shares well over $100.
RSPP RSP Permian
$36.09

-0.61 (-1.66%)

01/22/18
ROTH
01/22/18
NO CHANGE
Target $50.5
ROTH
Buy
RSP Permian price target raised to $50.50 from $44 at Roth Capital
Roth Capital analyst John White raised his price target for RSP Permian to $50.50 from $44 on higher 2018 WTI crude oil price estimates. The analyst reiterates a Buy rating on the shares.
02/01/18
DBAB
02/01/18
INITIATION
Target $55
DBAB
Buy
RSP Permian initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Nitin Kumar started RSP Permian with a Buy rating and $55 price target.
01/29/18
JRCO
01/29/18
UPGRADE
JRCO
Buy
RSP Permian upgraded to Buy from Accumulate at Johnson Rice
01/23/18
FBCO
01/23/18
NO CHANGE
Target $51
FBCO
Outperform
RSP Permian price target raised to $51 from $44 at Credit Suisse
Credit Suisse analyst Betty Jiang raised her price target for RSP Permian to $51 from $44 on valuation. The analyst reiterates an Outperform rating on the shares.
DXCM DexCom
$56.97

0.61 (1.08%)

02/12/18
OPCO
02/12/18
NO CHANGE
Target $67
OPCO
Outperform
Dexcom price target lowered to $67 from $72 at Oppenheimer
Oppenheimer analyst Steven Lichtman lowered his price target for Dexcom (DXCM) to $67 from $72 on lowered estimates, while reiterating an Outperform rating on the stock. The analyst recently surveyed high-volume U.S. endocrinologists on the latest in continuous glucose monitoring now with Abbott's (ABT) Libre Flash on the market. According to respondents, there is some impact on Dexcom new prescriptions since Libre launch and some current Dexcom patients are interested in switching, but the impact looks within expectations, he contends. Overall, Lichtman believes the rollouts of Libre and Medtronic's (MDT) 670G remain overhangs on Dexcom near-term, but his survey suggests an environment no worse than guidance and conditions on the ground should change again in 2H18 with approval of Dexcom's next-generation G6.
01/30/18
PIPR
01/30/18
NO CHANGE
Target $60
PIPR
Overweight
Study shows superior outcomes for Dexcom over Abbott, says Piper Jaffray
Results of the I HART study that were published in the Diabetic Medicine journal showed superior outcomes for those on the Dexcom's (DXCM) G5 compared to Abbott's (ABT) Libre, Piper Jaffray analyst JP McKim tells investors in a research note. Specifically, G5 reduced time spent in hypoglycaemia both during the day and at night versus Libre that actually increased time, McKim adds. The analyst believes that while patients in the trial were ideal Dexcom candidates given their increased risk of hypoglycemia, the data can be used to differentiate the technology in the eyes of payers. He believes both G5 and Libre have a place in the system for different patient populations. The analyst keeps an Overweight rating on Dexcom with a $60 price target.
02/26/18
PIPR
02/26/18
NO CHANGE
Target $60
PIPR
Overweight
Medtronic news incremental negative for Dexcom, says Piper Jaffray
Medtronic (MDT) this morning announced it received a new arm indication for its Guardian Sensor 3 which improves the accuracy of the sensor to an 8.7% MARD, likely leading to a non-adjunctive claim for standalone, Piper Jaffray analyst JP McKim tells investors in a research note. The news is an incremental negative for Dexcom (DXCM) shares as a path to non-adjunctive claim for Medtronic has become much clearer, McKim contends. He expects a stand-alone launch of Guardian Sensor 3 sometime in 2018. The analyst believes Dexcom carries more negative headline risk in the near term, but he expects the company to remain the market leader in continuous glucose monitors. As such, McKim thinks longer term investors should be buying the stock. He keeps an Overweight rating on Dexcom with a $60 price target. The stock in morning trading is down 12c to $56.24.
02/27/18
JPMS
02/27/18
NO CHANGE
JPMS
Abbott's strong Libre launch supports cautious Dexcom stance, says JPMorgan
Abbott's Libre launch is off to a strong start in the U.S. with more than 25,000 patients having started on the device since the launch in early December, JPMorgan analyst Michael Weinstein tells investors in a research note. It remains way too early, however, to say what percent of patients will stick with the device, the analyst adds. The Libre launch reinforces the analyst's cautious stance on shares of Dexcom (DXCM). He expects Dexcom's growth to slow over the course of the year and for 2019 to prove "much more challenging" than 2018. Weinstein has an Overweight rating on Abbott and Neutral rating on Dexcom.
WTW Weight Watchers
$70.13

-1.53 (-2.14%)

02/07/18
CHLM
02/07/18
NO CHANGE
Target $80
CHLM
Buy
Weight Watchers price target raised to $80 from $70 at Craig-Hallum
Craig-Hallum analyst Alex Fuhrman raised his price target for Weight Watchers to $80 from $70, saying he sees "great" buying opportunity following ambitious 2020 revenue goal of $2B which could set up Weight Watchers for about $4.50 in EPS. The analyst reiterates a Buy rating on the shares.
02/06/18
CHLM
02/06/18
NO CHANGE
Target $70
CHLM
Buy
Craig-Hallum sees good buying opportunity ahead of Weight Watchers event
Craig-Hallum analyst Alex Fuhrman notes that Weight Watchers announced it will webcast a global employee event on February 7. The analyst sees a "good buying opportunity" ahead of tomorrow's webcast employee event in which Weight Watchers is expected to unveil three-year goals. Fuhrman reiterates a Buy rating and $70 price target on the shares.
01/19/18
CHLM
01/19/18
NO CHANGE
Target $70
CHLM
Buy
Weight Watchers paid length of stay increasing due to Connect, says Craig-Hallum
Craig-Hallum analyst Alex Fuhrman said Connect, Weight Watchers' social media platform, is possibly "the most important change to happen in the last 5 years" at the company and he attributes the rise of the platform as the reason that paid length of stay has just started to increase for the first time in years. The analyst, who thinks this trend is "just getting started" based on his positive view of the Connect platform, keeps a Buy rating and $70 price target on Weight Watchers shares.
02/08/18
RILY
02/08/18
NO CHANGE
Target $86
RILY
Buy
Weight Watchers price target raised to $86 from $65 at B. Riley FBR
B. Riley FBR analyst Kara Anderson raised her price target for Weight Watchers to $86 after the company laid out a strategic vision and three-year plan that included a fiscal 2020 revenue target of $2B, which the analyst notes is well above expectations. Commentary on the reception of Weight Watchers' new plan for the 2018 diet season is "very positive," the analyst adds. She keeps an Overweight rating on the shares.
EVHC Envision Healthcare
$36.67

-0.005 (-0.01%)

12/19/17
JEFF
12/19/17
NO CHANGE
Target $41
JEFF
Buy
Envision can go private at over $40 per share, says Jefferies
Jefferies analyst Brian Tanquilut believes Envision Healthcare's announcement of a formal strategic review process has attracted private equity interest in the company. The likelihood of a takeout is high, particularly given the company's transaction history, Tanquilut tells investors in a research note. He believes Envision can go private at greater than $40 per share, even with the company's "pressured" near-term earnings power. Tanquilut lowered his price target for Envision Healthcare shares to $41 from $71 and keeps a Buy rating on the name.
01/31/18
FBCO
01/31/18
NO CHANGE
Target $43.5
FBCO
Outperform
Envision Healthcare price target raised to $43.50 from $36 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for Envision Healthcare to $43.50 from $36 as he thinks the company has a good chance at reporting a positive Q4. The analyst also reiterates an Outperform rating on the shares.
12/19/17
JEFF
12/19/17
NO CHANGE
JEFF
Jefferies sees attractive leveraged buyout candidates in Healthcare Services
The changing healthcare landscape, as well as the cyclicality of sector trends and the expected demographics-driven inflection in broader healthcare utilization in the coming years, have opened opportunities for increased private equity involvement in the Healthcare Services group, Jefferies analyst Brian Tanquilut tells investors in a research note. The analyst's quantitative screen and qualitative analysis points to Acadia (ACHC), BioScrip (BIOS) and Envision Healthcare (EVHC) as the "most feasible" leverage buyout candidates in his coverage universe. Tanquilut notes that while AmerisourceBergen (ABC) and McKesson (MCK) also screened as potential leveraged buyout candidates in his analysis, the equity checks required to take both private are likely too large, even for a consortium.
12/22/17
CANT
12/22/17
NO CHANGE
Target $30
CANT
Neutral
Envision rallied on withdraw from conference, says Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph France attributes the 6% rally yesterday in shares of Envision Healthcare to news that the company has withdrawn from JPMorgan's healthcare conference scheduled for next month. Envision announced a strategic review in November, and the analyst does not assume that yesterday's development means a transaction is imminent. It is possible that management cannot present because it is not in a position to comment on its outlook or the pending strategic review, France tells investors in a research note after speaking to management. The analyst keeps a Neutral rating on the shares with a $30 price target.
MTZ MasTec
$51.80

-0.95 (-1.80%)

01/18/18
FBCO
01/18/18
NO CHANGE
Target $69
FBCO
Outperform
MasTec price target raised to $69 from $58 at Credit Suisse
Credit Suisse analyst Jamie Cook raised his price target for MasTec to $69 from $58 to reflect the lower tax rate as a result of tax reform. The analyst reiterates an Outperform rating on the shares.
11/06/17
BARD
11/06/17
UPGRADE
Target $53
BARD
Outperform
MasTec upgraded to Outperform at Baird
As reported previously, Baird analyst Andrew Wittmann upgraded MasTec to Outperform from Neutral citing better secular growth opportunities within MasTec's end markets, which he believes should support multi-year earnings growth while the stock is still at modest valuation levels. Wittmann raised his price target to $53 from $51 on MasTec shares.
01/02/18
CHLM
01/02/18
NO CHANGE
Target $64
CHLM
Buy
MasTec price target raised to $64 from $57 at Craig-Hallum
Craig-Hallum analyst Christian Schwab raised his price target for MasTec to $64 from $57, citing the recent passage of the U.S. tax reform bill. Including local, state and other taxes, the analyst estimates MasTec's total effective tax rate going forward will be in the high 20's percent range. He reiterates a Buy rating on the shares.
12/12/17
LEHM
12/12/17
INITIATION
Target $54
LEHM
Overweight
MasTec initiated with an Overweight at Barclays
Barclays analyst Adam Seiden started MasTec with an Overweight rating and $54 price target.
OUT Outfront Media
$21.67

-0.545 (-2.45%)

06/05/17
LOOP
06/05/17
UPGRADE
Target $27
LOOP
Buy
Outfront Media upgraded to Buy from Hold at Loop Capital
Loop Capital analyst David Miller upgraded Outfront Media to Buy and raised his price target for the shares to $27 from $25. The analyst believes the "reward outweighs the risk" with the shares down 17% over the past 15 weeks. The current 6.3% dividend yield is "compelling by any measure," Miller tells investors in a research note. He believes a dividend cut is unlikely.
09/28/17
LOOP
09/28/17
NO CHANGE
LOOP
Outfront Media price target raised to $28 at Loop Capital
Loop Capital analyst David Miller raised his price target on Outfront Media to $28 from $27 and maintained his Buy rating after the company held a conference call going over its new NYC Mass Transit contract, where Outfront Media "will not only continue as the sole vendor, but will do so at measurably better economics" for the NYC subway, rails, and buses for a ten-year term. Miller calls the contract an "overhang fully lifted" that leaves no reason not to buy the stock.
07/13/17
LOOP
07/13/17
NO CHANGE
LOOP
Buy
Outfront may benefit from strong TV ad market 'spillover,' says Loop Capital
Loop Capital analyst David Miller said his contacts within the media buying community are discussing a "spillover effect" from the much better than expected TV upfronts that is causing certain advertisers to be priced out of television and move to out-of-home instead. The greatest beneficiary could be Outfront Media (OUT), because much of its revenues come from national advertisers, compared to competitor Lamar Advertising (LAMR), which is more locally focused, Miller tells investors. He keeps Buy ratings on both Outfront and Lamar.
06/05/17
06/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Yelp (YELP) upgraded to Buy from Neutral at BofA/Merrill with analyst Justin Post saying consensus estimates are achievable following the first quarter headline miss. The analyst sees improved quarterly net account adds ahead and improved execution driving shares higher. 2. Exxon Mobil (XOM) upgraded to Outperform from Sector Perform at Scotia Howard Weil with the firm saying recent weakness provides a buying opportunity for this defensive play within the oil patch. 3. eBay (EBAY) upgraded to Outperform from Neutral at Credit Suisse with analyst Paul Bieber assuming coverage on the stock while saying there are multiple paths to create value. 4. Gap (GPS) upgraded to Outperform from Perform at Oppenheimer with analyst Anna Andreeva saying the shares are down 17% from last month's highs despite the retailer posting 12% earnings growth in the first quarter. 5. Outfront Media (OUT) upgraded to Buy from Hold at Loop Capital with analyst David Miller saying he believes the "reward outweighs the risk" with the shares down 17% over the past 15 weeks. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ETSY Etsy
$21.12

0.05 (0.24%)

02/21/18
DADA
02/21/18
NO CHANGE
Target $26
DADA
Buy
Etsy price target raised to $26 from $20 at DA Davidson
DA Davidson analyst Tom Forte raised his price target on Etsy to $26, saying the new management is exploiting the company's business model - "one of the analyst's favorites in consumer technology". Forte cites the management's progress with the payment system as well as capitalizing on the opportunity of the holiday selling period, which should produce positive results in Q4, and carry the innovation momentum into Q1-Q2. The analyst keeps his Buy rating on Etsy.
01/12/18
01/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Facebook (FB) downgraded to Hold from Buy at Stifel with analyst Scott Devitt arguing there is currently "too much uncertainty" relating to the economic impact of the company's pending News Feed changes communicated in a post last night by CEO Mark Zuckerberg. 2. Snap (SNAP) downgraded to Underperform from Market Perform at Raymond James with analyst Aaron Kessler saying Snap is largely a Chat/Message app and not a camera company as it refers to itself. 3. Etsy (ETSY) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Brian Nowak citing valuation as being too expensive compared to its peers and the stock's historical average. 4. Comcast (CMCSA) downgraded to Buy from Action List Buy at TD Securities with analyst Vince Valentin citing recent shares strength and to make room of new Action List addition Shaw Communications (SJR), where he now sees better upside potential. 5. Electronic Arts (EA) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Brian Nowak citing disappointing "Star Wars: Battlefront 2" third party data. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/20/17
KEYB
12/20/17
INITIATION
Target $26
KEYB
Overweight
Etsy initiated with an Overweight at KeyBanc
KeyBanc analyst Jason Gere started Etsy with an Overweight rating and $26 price target. The analyst says underlying double-digit secular growth, greater than 15% adjusted EBITDA margins and "visible self-help initiatives" make the company "unique" within e-commerce.
01/12/18
MSCO
01/12/18
DOWNGRADE
Target $17
MSCO
Underweight
Etsy downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Brian Nowak downgraded Etsy to Underweight from Equal Weight, primarily citing valuation as being too expensive compared to its peers and the stock's historical average. Without evidence that the company's new management can drive faster than expected revenue growth, he believes investors may not continue to be willing to buy the stock at its current multiple, Nowak tells investors. However, given estimated cost savings from cloud migration and a lower expected tax rate, Nowak raised his price target on Etsy shares to $17 from $13.50.
BGS B&G Foods
$31.60

-0.4 (-1.25%)

11/16/17
BREN
11/16/17
UPGRADE
BREN
Buy
B&G Foods upgraded to Buy from Hold at Berenberg
Bernenberg analyst Adam Mizrahl upgraded B&G Foods to Buy and raised its price target to $40 from $34 saying Green Giant potential is underestimated and tail brand declines are overestimates.
08/23/17
BUCK
08/23/17
UPGRADE
BUCK
Buy
B&G Foods upgraded to Buy from Neutral at Buckingham
11/01/17
SPHN
11/01/17
UPGRADE
Target $39
SPHN
Overweight
B&G Foods upgraded to Overweight from Equal Weight at Stephens
Stephens analyst Farha Aslam upgraded B&G Foods to Overweight from Equal Weight, citing the company's strong innovation, better execution and accretive acquisitions. The shares also have a "compelling" 5.7% dividend yield, added Aslam, who raised her price target on B&G to $39 from $35.
08/23/17
BUCK
08/23/17
UPGRADE
BUCK
Buy
B&G Foods upgraded on improved outlook at Buckingham
As noted earlier, Buckingham upgraded B&G to Buy from Neutral. Analyst Eric Larson says that the company "is becoming more consolidated, with increasing exposure to advantaged categories." He thinks this trend will cause its profits to rise over the longer term, and he says that the company's comparisons are set to become more favorable. Target $40.
PZZA Papa John's
$57.27

0.07 (0.12%)

12/18/17
12/18/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Twitter (TWTR) initiated with a Buy at Summit Redstone. 2. Insteel (IIIN) initiated with a Buy at Sidoti. 3. Tiffany (TIF) initiated with a Neutral at JPMorgan. 4. Delphi Technologies (DLPH) initiated with a Buy at Jefferies. 5. Domino's Pizza (DPZ) initiated with a Buy at Deutsche Bank, while Papa John's and Wingstop (WING) were initiated with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/22/17
NOMU
12/22/17
NO CHANGE
Target $58
NOMU
Neutral
Papa John's price target lowered to $58 from $65 at Nomura Instinet
Nomura Instinet analyst Mark Kalinowski lowered his price target for Papa John's International to $58 saying the CEO change suggests a "rough" Q4 for the company following adverse media attention. To reflect "weakened momentum in the business," the analyst cut his 2018 earnings per share estimate to $2.75 from $3.00 and keeps a Neutral rating on Papa John's.
12/18/17
DBAB
12/18/17
INITIATION
Target $63
DBAB
Hold
Papa John's initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Brett Levy started Papa John's with a Hold rating and $63 price target. The analyst finds the shares fairly valued given the company's "sluggish and less inspiring" recent results.
02/27/18
OPCO
02/27/18
NO CHANGE
Target $75
OPCO
Outperform
Papa John's a more logical target for Restaurant Brands, says Oppenheimer
Oppenheimer analyst Brian Bittner says that while Domino's Pizza (DPZ) has been the center of speculation, his analysis suggests Papa John's (PZZA) represents the most logical target for Restaurant Brands (QSR). The analyst points out that Domino's Pizza larger size and valuation would require a major equity raise whereas Papa John's could be fully-funded internally by cash and pro-forma leverage. Domino's Pizza fundamentals are best-in-class, but Papa John's anatomy better fits Restaurant Brands' deal characteristics, he contends. Bittner reiterates an Outperform rating and $75 price target on Restaurant Brands' shares.
HTZ Hertz
$19.29

-0.73 (-3.65%)

01/18/18
01/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Walmart (WMT) upgraded to Conviction Buy from Neutral at Goldman Sachs with analyst Matthew Fassler saying selling consumables to middle-income consumers in small markets remains a compelling strategic position. 2. Hertz (HTZ) upgraded to Outperform from Neutral at Macquarie with analyst Hamzah Mazari saying he is more bullish on 2018 rental car pricing given fleet cutting by Enterprise, the positive impact on corporate travel from tax reform, and the potential US infrastructure bill creating excess demand. For Hertz specifically. 3. Alarm.com (ALRM) upgraded to Buy from Hold at Jefferies analyst John DiFucci saying Alarm.com is at the forefront of the trend towards connected homes and devices. 4. PPL Corp. (PPL) upgraded to Buy from Hold at Deutsche Bank with analyst Jonathan Arnold saying the current valuation is "too cheap to ignore," and U.K. energy regulator Ofgem failing to implement a mid-period review of RIIO-ED1 offers "decent prospects for a near-term re-rating catalyst." 5. Fluor (FLR) upgraded to Outperform from Neutral at Credit Suisse with analyst Jamie Cook saying investors will gravitate back to Engineering & Construction stocks as fundamentals for the group are improving. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/18/18
MACQ
01/18/18
UPGRADE
MACQ
Outperform
Hertz upgraded to Outperform on improving industry trends at Macquarie
Macquarie analyst Hamzah Mazari upgraded Hertz to Outperform and raised its price target to $30 from $26. Mazari is more bullish on 2018 rental car pricing given fleet cutting by Enterprise, the positive impact on corporate travel from tax reform, and the potential US infrastructure bill creating excess demand. For Hertz specifically, Mazari said expectations are low, investment spending is rolling off, and the industry is operating as a more "functional oligopoly."
01/18/18
MACQ
01/18/18
UPGRADE
MACQ
Outperform
Hertz upgraded to Outperform from Neutral at Macquarie
12/01/17
MSCN
12/01/17
NO CHANGE
MSCN
Hertz mentioned positively at MScience
IMAX Imax
$23.35

-0.3 (-1.27%)

02/20/18
02/20/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Imax (IMAX) assumed with an Overweight at JPMorgan. 2. Gates Industrial (GTES) was initiated with an Outperform at RBC Capital and Credit Suisse, an Overweight at Morgan Stanley and KeyBanc, as well as a Buy at SunTrust, UBS, and Citi. 3. Menlo Therapeutics (MNLO) was initiated with an Outperform at JMP Securities, an Overweight at Piper Jaffray, and a Buy at Jefferies. 4. PlayAGS (AGS) was initiated with a Buy at SunTrust, BofA/Merrill, and Deutsche Bank. 5. PagSeguro Digital (PAGS) was initiated with a Neutral at JPMorgan, BofA/Merrill, UBS, and Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/18
01/10/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hershey (HSY) downgraded to Underweight from Equal Weight by Morgan Stanley analyst Matthew Grainger, who said Hershey shares have meaningfully outperformed peers over the last twelve months, giving the stock a valuation premium well above its historical norm, though he does not believe that valuation gap can be maintained given the company's need for increased reinvestment paired with slowing category growth and share weakness. 2. Barclays (BCS) and Lloyds Banking (LYG) downgraded to Equal Weight from Overweight at Morgan Stanley by analyst Alvaro Serrano, who said that while he is more optimistic on its margin outlook than consensus he sees the stock having less room for a re-rating than peers given its current valuation. 3. IMAX (IMAX) downgraded to Neutral from Overweight at Piper Jaffray by analyst Stan Meyers, who sees the stock being pressured by another wave of major estimate revisions for Q4 and 2018, continued loss of casual fans and an oversaturated market in China. The analyst lowered his 2018 box office expectations from growth of 18% to growth of 3%. 4. Alaska Air (ALK) downgraded to Equal Weight from Overweight at Barclays by analyst Joseph Wolf, who believes the company needs "close to flawless" execution as a minimum requirement for the shares to perform. He sees relatively high risk in the stock. 5. Big Lots (BIG) downgraded to Perform from Outperform at Oppenheimer. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/20/18
JPMS
02/20/18
INITIATION
Target $28
JPMS
Overweight
Imax assumed with an Overweight at JPMorgan
JPMorgan analyst Julia Yue assumed coverage of Imax with an Overweight rating and $28 price target. The analyst calls the company her top 2018 cinema stock. She sees ongoing elevated level of installations and "revenue-enhancing" strategies driving "healthy" box office and revenue growth.
01/10/18
PIPR
01/10/18
DOWNGRADE
Target $21
PIPR
Neutral
IMAX downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Stan Meyers downgraded IMAX to Neutral and cut his price target for the shares to $21 from $28. The analyst sees the stock being pressured by another wave of major estimate revisions for Q4 and 2018, continued loss of casual fans and an oversaturated market in China. The analyst lowered his 2018 box office expectations from growth of 18% to growth of 3%.

TODAY'S FREE FLY STORIES

BA

Boeing

$356.95

0.94 (0.26%)

19:10
07/17/18
07/17
19:10
07/17/18
19:10
Hot Stocks
Boeing awarded $3.9B government contract »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MRTN

Marten Transport

$22.10

(0.00%)

, UAL

United Continental

$72.66

0.38 (0.53%)

19:03
07/17/18
07/17
19:03
07/17/18
19:03
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Martin…

MRTN

Marten Transport

$22.10

(0.00%)

UAL

United Continental

$72.66

0.38 (0.53%)

CSX

CSX

$64.42

0.46 (0.72%)

MLNX

Mellanox

$84.85

0.9 (1.07%)

IBKR

Interactive Brokers

$64.65

1.93 (3.08%)

HCSG

Healthcare Services

$42.38

-0.3297 (-0.77%)

TXN

Texas Instruments

$115.80

1.21 (1.06%)

SAH

Sonic Automotive

$20.45

0.3 (1.49%)

CARA

Cara Therapeutics

$21.60

0.435 (2.06%)

CASI

Casi Pharmaceuticals

$7.26

-0.215 (-2.88%)

TLYS

Tilly's

$15.35

0.21 (1.39%)

CLX

Clorox

$135.00

0.71 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 18

    Jul

  • 18

    Jul

  • 24

    Jul

  • 02

    Aug

  • 26

    Aug

  • 19

    Jul

BHP

BHP Billiton

$48.73

0.24 (0.49%)

18:38
07/17/18
07/17
18:38
07/17/18
18:38
Hot Stocks
BHP Billiton sees FY19 copper equivalent output broadly in line with FY18 »

Says expects to achieve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHP

BHP Billiton

$48.73

0.24 (0.49%)

18:35
07/17/18
07/17
18:35
07/17/18
18:35
Hot Stocks
BHP Billiton reports Q4 petroleum production 49 MMBOE, down 6% »

Reports Q4 copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$135.00

0.71 (0.53%)

18:31
07/17/18
07/17
18:31
07/17/18
18:31
Downgrade
Clorox rating change  »

Clorox downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

NCS

NCI Building

$20.70

0.15 (0.73%)

18:27
07/17/18
07/17
18:27
07/17/18
18:27
Hot Stocks
NCI Building Systems, Ply Gem Parent to combine in stock-for-stock merger »

NCI Building Systems and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMX

America Movil, also tag AMOV

$17.39

-0.35 (-1.97%)

, AMOV

America Movil, also tag AMX

$17.45

-0.19 (-1.08%)

18:16
07/17/18
07/17
18:16
07/17/18
18:16
Earnings
America Movil reports Q2 operating profit MXN32.6M, up 4.8% from last year »

Reports Q2 revenue…

AMX

America Movil, also tag AMOV

$17.39

-0.35 (-1.97%)

AMOV

America Movil, also tag AMX

$17.45

-0.19 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,844.00

21.98 (1.21%)

18:08
07/17/18
07/17
18:08
07/17/18
18:08
Recommendations
Amazon.com analyst commentary  »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

  • 16

    Aug

BRK.A

Berkshire Hathaway

$288,482.00

-1118 (-0.39%)

, BRK.B

Berkshire Hathaway

$190.47

-1.52 (-0.79%)

18:06
07/17/18
07/17
18:06
07/17/18
18:06
Hot Stocks
Berkshire Hathaway amends share repurchase program »

The Board of Directors of…

BRK.A

Berkshire Hathaway

$288,482.00

-1118 (-0.39%)

BRK.B

Berkshire Hathaway

$190.47

-1.52 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNFP

Pinnacle Financial

$60.10

-0.5 (-0.83%)

18:02
07/17/18
07/17
18:02
07/17/18
18:02
Earnings
Pinnacle Financial reports Q2 EPS $1.15, consensus $1.14 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Sep

CHDN

Churchill Downs

$304.60

1.1 (0.36%)

18:02
07/17/18
07/17
18:02
07/17/18
18:02
Hot Stocks
Churchill Downs receives approval to increase historical racing machines »

Churchill Downs announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

CE

Celanese

$110.22

1.6 (1.47%)

18:01
07/17/18
07/17
18:01
07/17/18
18:01
Hot Stocks
Celanese announces acetic acid price increases in Asia »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

BLK

BlackRock

$504.89

1.14 (0.23%)

17:51
07/17/18
07/17
17:51
07/17/18
17:51
Hot Stocks
BlackRock raises quarterly dividend to $3.13 from $2.88 per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRNA

Dicerna

$12.47

0.57 (4.79%)

17:45
07/17/18
07/17
17:45
07/17/18
17:45
Conference/Events
Dicerna management to meet with SunTrust »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

GOOG

Alphabet

$1,198.81

14.57 (1.23%)

, GOOGL

Alphabet Class A

$1,213.65

17.07 (1.43%)

17:44
07/17/18
07/17
17:44
07/17/18
17:44
Periodicals
Google faces record EU fine over Android dominance, FT reports »

Alphabet's Google…

GOOG

Alphabet

$1,198.81

14.57 (1.23%)

GOOGL

Alphabet Class A

$1,213.65

17.07 (1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 23

    Jul

  • 23

    Jul

  • 08

    Aug

  • 18

    Sep

  • 28

    Oct

BA

Boeing

$356.95

0.94 (0.26%)

17:39
07/17/18
07/17
17:39
07/17/18
17:39
Periodicals
Breaking Periodicals news story on Boeing »

Boeing awarded $3.9B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GWR

Genesee & Wyoming

$80.62

-0.88 (-1.08%)

17:34
07/17/18
07/17
17:34
07/17/18
17:34
Hot Stocks
Genesee & Wyoming reports June total traffic down 1.2% »

G&W's total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BLMN

Bloomin' Brands

$20.79

0.07 (0.34%)

17:19
07/17/18
07/17
17:19
07/17/18
17:19
Recommendations
Bloomin' Brands analyst commentary  »

Current pullback in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

TLYS

Tilly's

$15.35

0.21 (1.39%)

17:13
07/17/18
07/17
17:13
07/17/18
17:13
Syndicate
Breaking Syndicate news story on Tilly's »

Tilly's files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUUU

Energy Fuels

$2.30

0.03 (1.32%)

, URG

UR-Energy

$0.66

-0.0068 (-1.02%)

17:10
07/17/18
07/17
17:10
07/17/18
17:10
Periodicals
Trump admin plans to probe uranium imports, may lead to tariffs, Bloomberg says »

The Trump administration…

UUUU

Energy Fuels

$2.30

0.03 (1.32%)

URG

UR-Energy

$0.66

-0.0068 (-1.02%)

CCJ

Cameco

$10.93

0.16 (1.49%)

WWR

Westwater Resources

$0.37

-0.0023 (-0.62%)

UEC

Uranium Energy

$1.55

-0.015 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

BPI

Bridgepoint Education

$7.01

0.215 (3.17%)

17:08
07/17/18
07/17
17:08
07/17/18
17:08
Hot Stocks
Bridgepoint Education receives approval to merge subsidiary institutions »

Bridgepoint Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

HTH

Hilltop Holdings

$21.49

-0.39 (-1.78%)

17:06
07/17/18
07/17
17:06
07/17/18
17:06
Hot Stocks
Hilltop Holdings announces approval for $85M Bank of River Oaks acquisition »

Hilltop Holdings and The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 24

    Sep

HWC

Hancock Whitney Corporation

$48.35

-0.1 (-0.21%)

17:03
07/17/18
07/17
17:03
07/17/18
17:03
Earnings
Hancock Whitney Corporation reports Q2 adjusted EPS 96c, consensus 95c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

MEOH

Methanex

$71.15

1.4 (2.01%)

17:03
07/17/18
07/17
17:03
07/17/18
17:03
Hot Stocks
Methanex reaches long-term pact for natural gas supply to New Zealand ops »

Methanex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$115.80

1.21 (1.06%)

17:01
07/17/18
07/17
17:01
07/17/18
17:01
Hot Stocks
Breaking Hot Stocks news story on Texas Instruments »

Texas Instruments down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.